riliprubart Clinical Trials (2026): 3 Studies for Polyneuropathy, Inflammatory Demyelinating, Chronic & Chronic Inflammatory Demyelinating Polyneuropathy

Where to Participate: All riliprubart Trial Sites in the U.S. (56 sites across 21 states)

Every actively recruiting riliprubarttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

riliprubart clinical trials at a glance: phase × recruitment status

Recruiting riliprubart clinical trials (3)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

riliprubart clinical trials by indication

riliprubart pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All riliprubart trials (3)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

riliprubart clinical trials: frequently asked questions

How many riliprubart clinical trials are there?

3 riliprubart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants.

Are riliprubart clinical trials recruiting in 2026?

Yes — 3 riliprubart trials are actively recruiting in 2026, with 56 U.S. sites across 21 states. See the recruiting trials and the per-state site list further down this page.

What conditions is riliprubart being studied for?

riliprubart is being studied for Polyneuropathy, Inflammatory Demyelinating, Chronic, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy. The trials are grouped by indication on this page.

What phase is riliprubart in?

riliprubart clinical trials span 3 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors riliprubart clinical trials?

The lead sponsor across the most riliprubart trials is Sanofi. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming riliprubartas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.